GC Biopharma gets US FDA approval for Alyglo 10% liquid for adults with primary humoral immunodeficiency
Pharmabiz.com,
GC Biopharma Corporation, a biopharmaceutical company that delivers lifesaving and life-sustaining protein therapeutics and…
Alyglo Approved for Patients With Primary Humoral Immunodeficiency
MPR,
The Food and Drug Administration (FDA) has approved GC Biopharma’s Alyglo (immune globulin intravenous, human-stwk) 10% liquid…
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
ProfitQuotes.com,
YOGIN, South Korea, Dec. 17, 2023 -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA…
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
Yahoo! Finance USA,
, /PRNewswire/ GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO …